VSV-EBOVAC brings together 12 leading international, both clinical and high tech, vaccine research institutes from 6 EU countries and USA as well as two African clinical sites. The partners provide state-of-the art facilities and clinical vaccination research infrastructures that will work together to facilitate Ebola vaccine development.
The VSV-EBOVAC project is coordinated by the Sclavo Vaccines Association (www.sclavo.org), a non-profit organization devoted to support research and development of human vaccines.
VSV-EBOVAC Partners
Third Parties:
